Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://karinbentum.nl
Are you over 18 and want to see adult content?
A complete backup of https://ebloger.net
Are you over 18 and want to see adult content?
A complete backup of https://rosetoys.eu
Are you over 18 and want to see adult content?
A complete backup of https://villagecafe.com.au
Are you over 18 and want to see adult content?
A complete backup of https://dten.com
Are you over 18 and want to see adult content?
A complete backup of https://cgslb.be
Are you over 18 and want to see adult content?
A complete backup of https://capistranorb.com
Are you over 18 and want to see adult content?
A complete backup of https://zolmax.com
Are you over 18 and want to see adult content?
A complete backup of https://mojomarketplace.com
Are you over 18 and want to see adult content?
A complete backup of https://avisen.dk
Are you over 18 and want to see adult content?
A complete backup of https://slow-cosmetique.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://crimzon.co.uk
Are you over 18 and want to see adult content?
A complete backup of https://mcqueenonline.com
Are you over 18 and want to see adult content?
A complete backup of https://ohs.org.uk
Are you over 18 and want to see adult content?
A complete backup of https://d3lta.me
Are you over 18 and want to see adult content?
A complete backup of https://profamilia.org.co
Are you over 18 and want to see adult content?
A complete backup of https://neticrm.tw
Are you over 18 and want to see adult content?
A complete backup of https://klosterbraeu.com
Are you over 18 and want to see adult content?
A complete backup of https://hkmdb.com
Are you over 18 and want to see adult content?
A complete backup of https://wattis.org
Are you over 18 and want to see adult content?
A complete backup of https://maxsdeals.co.uk
Are you over 18 and want to see adult content?
A complete backup of https://equinocciovalladolid.com
Are you over 18 and want to see adult content?
A complete backup of https://pfimegalife.co.id
Are you over 18 and want to see adult content?
Text
CENTENARY BEGINS
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being.SITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
PARTNER PORTAL USER INSTRUCTIONS ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. ORION'S R&D PIPELINE Orion's Easyhaler® is an in-house developed dry-powder inhaler. Orion has developed Easyhaler-adapted dry powder formulations of several well-known generic active substances (salbutamol, beclometasone, budesonide, formoterol and budesonide-formoterol combination) ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED Orion Research Foundation grants for 2022 can be applied for between 1 August and 10 September 2021. Grants are designated to support academic research for Finnish medicine, veterinary medicine, pharmacy and natural sciences related to those, such as chemistry and physics according Orion Research Foundation’s rulesORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
ORIONIN ELÄKESÄÄTIÖLAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. ORIONORION GROUPCAREERS AT ORIONRESEARCHHEALTH PROFESSIONALSORION'SCENTENARY BEGINS
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being.SITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
PARTNER PORTAL USER INSTRUCTIONS ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. ORION'S R&D PIPELINE Orion's Easyhaler® is an in-house developed dry-powder inhaler. Orion has developed Easyhaler-adapted dry powder formulations of several well-known generic active substances (salbutamol, beclometasone, budesonide, formoterol and budesonide-formoterol combination) ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED Orion Research Foundation grants for 2022 can be applied for between 1 August and 10 September 2021. Grants are designated to support academic research for Finnish medicine, veterinary medicine, pharmacy and natural sciences related to those, such as chemistry and physics according Orion Research Foundation’s rulesORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
ORIONIN ELÄKESÄÄTIÖLAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. PRODUCTS AND SERVICES Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Get acquainted with our products and services. ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms.INVESTORS | ORION
Financial reviews and presentations. Orion published Interim Report for January–March 2021 on Tuesday, 27 April 2021. The release and related presentation material as well as link to the live webcast and teleconference details are available here. Read more. ORION’S CLINICAL TRIAL SHOWS SIGNIFICANT IMPROVEMENT FOR 6/9/2021 Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy. Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy PRESCRIPTION DRUGS AND SELF-CARE PRODUCTS Prescription drugs and self-care products. Orion has a wide range of primary healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. Our portfolio consists of a range of hundreds of products. Our product portfolio includes: Proprietary drugs developed by Orion itself. Substitutable genericdrugs.
ORION AND THE BLOOD SERVICE LAUNCH COLLABORATION TO 6/8/2021 Orion and the Blood Service launch collaboration to develop new CAR T-cell cancer therapy. Orion and the Blood Service launch collaboration to develop new CAR T ORION ANIMAL HEALTH’S BONQAT® (PREGABALIN) RECEIVES Orion Animal Health’s Bonqat® (pregabalin) receives positive CVMP opinion. ORION CORPORATION PRESS RELEASE 17 MAY 2021 at 15.00 EEST. The Committee for Medical Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has recommended Bonqat® (pregabalin) for marketing authorisation in the European Union.ORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. KIM NYLUND TO LEAD CONTRACT MANUFACTURING AT ORION Kim Nylund to lead Contract Manufacturing at Orion. Kim Nylund will be leading Contract Manufacturing at Orion as of August 1, 2018 as Esa Nauska will join the Orion External Supply Operations as Head of Outsourcing and Biosimilars. Kim Nylund has worked at Orion for 11 years and has extensive process development and project managementexperience.
LAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. ORIONORION GROUPCAREERS AT ORIONRESEARCHHEALTH PROFESSIONALSORION'SCENTENARY BEGINS
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being.SITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
PARTNER PORTAL USER INSTRUCTIONS ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. ORION'S R&D PIPELINE Orion's Easyhaler® is an in-house developed dry-powder inhaler. Orion has developed Easyhaler-adapted dry powder formulations of several well-known generic active substances (salbutamol, beclometasone, budesonide, formoterol and budesonide-formoterol combination) ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED Orion Research Foundation grants for 2022 can be applied for between 1 August and 10 September 2021. Grants are designated to support academic research for Finnish medicine, veterinary medicine, pharmacy and natural sciences related to those, such as chemistry and physics according Orion Research Foundation’s rulesORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
ORIONIN ELÄKESÄÄTIÖLAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. ORIONORION GROUPCAREERS AT ORIONRESEARCHHEALTH PROFESSIONALSORION'SCENTENARY BEGINS
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being.SITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
PARTNER PORTAL USER INSTRUCTIONS ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. ORION'S R&D PIPELINE Orion's Easyhaler® is an in-house developed dry-powder inhaler. Orion has developed Easyhaler-adapted dry powder formulations of several well-known generic active substances (salbutamol, beclometasone, budesonide, formoterol and budesonide-formoterol combination) ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED Orion Research Foundation grants for 2022 can be applied for between 1 August and 10 September 2021. Grants are designated to support academic research for Finnish medicine, veterinary medicine, pharmacy and natural sciences related to those, such as chemistry and physics according Orion Research Foundation’s rulesORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
ORIONIN ELÄKESÄÄTIÖLAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja. PRODUCTS AND SERVICES Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. Get acquainted with our products and services. ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms.INVESTORS | ORION
Financial reviews and presentations. Orion published Interim Report for January–March 2021 on Tuesday, 27 April 2021. The release and related presentation material as well as link to the live webcast and teleconference details are available here. Read more. ORION’S CLINICAL TRIAL SHOWS SIGNIFICANT IMPROVEMENT FOR 6/9/2021 Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy. Orion’s Clinical Trial Shows Significant Improvement for Chronic Pain Patients Using Virtual Reality Therapy PRESCRIPTION DRUGS AND SELF-CARE PRODUCTS Prescription drugs and self-care products. Orion has a wide range of primary healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. Our portfolio consists of a range of hundreds of products. Our product portfolio includes: Proprietary drugs developed by Orion itself. Substitutable genericdrugs.
ORION AND THE BLOOD SERVICE LAUNCH COLLABORATION TO 6/8/2021 Orion and the Blood Service launch collaboration to develop new CAR T-cell cancer therapy. Orion and the Blood Service launch collaboration to develop new CAR T ORION ANIMAL HEALTH’S BONQAT® (PREGABALIN) RECEIVES Orion Animal Health’s Bonqat® (pregabalin) receives positive CVMP opinion. ORION CORPORATION PRESS RELEASE 17 MAY 2021 at 15.00 EEST. The Committee for Medical Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has recommended Bonqat® (pregabalin) for marketing authorisation in the European Union.ORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. KIM NYLUND TO LEAD CONTRACT MANUFACTURING AT ORION Kim Nylund to lead Contract Manufacturing at Orion. Kim Nylund will be leading Contract Manufacturing at Orion as of August 1, 2018 as Esa Nauska will join the Orion External Supply Operations as Head of Outsourcing and Biosimilars. Kim Nylund has worked at Orion for 11 years and has extensive process development and project managementexperience.
LAATUPOLITIIKKAMME
Orionin laatupolitiikka luo yhteisen perustan laatutyölle lääkeliiketoiminnoissa. Laatupolitiikassamme on kuusi peruselementtiä: Lähtökohtana ovat asiakkaan tarpeet ja odotukset, joiden täyttäminen on Orionin menestymisen edellytys. Noudatamme toiminnassamme eettisiä periaatteita, voimassa olevia sääntöjä sekä Orionin arvoja.SITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
PARTNER PORTAL USER INSTRUCTIONSCMD 2021 | ORION
CMD 2021. Orion’s virtual Capital Markets Day 2021 for investors, analysts and media will be held on 26 May 2021 at 1.00 p.m – 4.00 p.m. EEST. At the event, Orion's management will provide an update on the company's strategy, business and research & development projects. The presentations will include updates from CEO Timo Lappalainen and ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED Orion Research Foundation grants for 2022 can be applied for between 1 August and 10 September 2021. Grants are designated to support academic research for Finnish medicine, veterinary medicine, pharmacy and natural sciences related to those, such as chemistry and physics according Orion Research Foundation’s rules AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
ORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. KIM NYLUND TO LEAD CONTRACT MANUFACTURING AT ORION Kim Nylund to lead Contract Manufacturing at Orion. Kim Nylund will be leading Contract Manufacturing at Orion as of August 1, 2018 as Esa Nauska will join the Orion External Supply Operations as Head of Outsourcing and Biosimilars. Kim Nylund has worked at Orion for 11 years and has extensive process development and project managementexperience.
CREATING A CULTURE OF PRODUCTIVITY AND COLLABORATIVE 42 | Research-Technology Management Creating a Culture of Productivity and Collaborative Innovation Orion’s pharmaceutical R&D group comprised 700 people across three sites in Finland (Espoo, Turku, Kuopio) and one in the United Kingdom (Nottingham). ODM-208, A NOVEL CYP11A1-INHIBITOR AS A THERAPEUTIC Worldwide prostate cancer (PCa) is the most common cancer in men and the prognosis for those patients, who develop castration-resistantprostate
INTRODUCTIONS OF EXECUTIVE MANAGEMENT BOARD MEMBERS 7.2 1 (2) Introductions of Executive Management Board members 7.2.2012 Timo Lappalainen M.Sc. (Eng) b. 1962 President and CEO of OrionCorporation,
SITES AND OFFICES
FinOrion Pharma India Pvt. Ltd. 501, 5th floor, A Wing, Everest Chambers Marol Naka, Andheri Kurla Road, Andheri ( East) Mumbai-400059 , INDIA
PARTNER PORTAL USER INSTRUCTIONSCMD 2021 | ORION
CMD 2021. Orion’s virtual Capital Markets Day 2021 for investors, analysts and media will be held on 26 May 2021 at 1.00 p.m – 4.00 p.m. EEST. At the event, Orion's management will provide an update on the company's strategy, business and research & development projects. The presentations will include updates from CEO Timo Lappalainen and ORION RESEARCH FOUNDATION GRANTS FOR 2022 CAN BE APPLIED Orion Research Foundation grants for 2022 can be applied for between 1 August and 10 September 2021. Grants are designated to support academic research for Finnish medicine, veterinary medicine, pharmacy and natural sciences related to those, such as chemistry and physics according Orion Research Foundation’s rules AN INHALER THAT HELPS ASTHMATICS AND THE ATMOSPHERE The mechanism of a ballpoint pen is the model for a new type of dispenser, and the Easyhaler inhaler for asthmatics is introduced in 1993. The new product has three goals: accurate dosage, ease of use and a propellant-free preparation. Freons provoke heated discussion in the early 1990s because of their detrimental effect on the ozonelayer.
ORIONSYDÄN
Päivitetty verenpaineoppaamme tarjoaa ajankohtaista tietoa kohonneen verenpaineen riskeistä ja hoidosta. Lue lisää. KIM NYLUND TO LEAD CONTRACT MANUFACTURING AT ORION Kim Nylund to lead Contract Manufacturing at Orion. Kim Nylund will be leading Contract Manufacturing at Orion as of August 1, 2018 as Esa Nauska will join the Orion External Supply Operations as Head of Outsourcing and Biosimilars. Kim Nylund has worked at Orion for 11 years and has extensive process development and project managementexperience.
CREATING A CULTURE OF PRODUCTIVITY AND COLLABORATIVE 42 | Research-Technology Management Creating a Culture of Productivity and Collaborative Innovation Orion’s pharmaceutical R&D group comprised 700 people across three sites in Finland (Espoo, Turku, Kuopio) and one in the United Kingdom (Nottingham). ODM-208, A NOVEL CYP11A1-INHIBITOR AS A THERAPEUTIC Worldwide prostate cancer (PCa) is the most common cancer in men and the prognosis for those patients, who develop castration-resistantprostate
INTRODUCTIONS OF EXECUTIVE MANAGEMENT BOARD MEMBERS 7.2 1 (2) Introductions of Executive Management Board members 7.2.2012 Timo Lappalainen M.Sc. (Eng) b. 1962 President and CEO of OrionCorporation,
ORION
Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. ABOUT US: ORION CONTRACT MANUFACTURING About us: Orion Contract Manufacturing. Orion is an innovative European R&D based pharmaceuticals company that offers high value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. PRESCRIPTION DRUGS AND SELF-CARE PRODUCTS Prescription drugs and self-care products. Orion has a wide range of primary healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. Our portfolio consists of a range of hundreds of products. Our product portfolio includes: Proprietary drugs developed by Orion itself. Substitutable genericdrugs.
ORION AND THE BLOOD SERVICE LAUNCH COLLABORATION TO 6/8/2021 Orion and the Blood Service launch collaboration to develop new CAR T-cell cancer therapy. Orion and the Blood Service launch collaboration to develop new CAR TAGM 2021 | ORION
AGM 2021. The Annual General Meeting of Orion Corporation was held on Thursday 25 March 2021 at Orion's Head Office in Espoo. The decisions and related material are available on this page. Stock Exchange Release: Decisions taken by Orion Corporation’s Annual GeneralMeeting on 25
ORION'S R&D PIPELINE Orion's Easyhaler® is an in-house developed dry-powder inhaler. Orion has developed Easyhaler-adapted dry powder formulations of several well-known generic active substances (salbutamol, beclometasone, budesonide, formoterol and budesonide-formoterol combination) CORPORATE GOVERNANCE In its administration Orion Corporation complies with current legislation and Finnish Corporate Governance Code 2010 for companies listed on NASDAQ OMX Helsinki. ORION ANIMAL HEALTH’S BONQAT® (PREGABALIN) RECEIVES Orion Animal Health’s Bonqat® (pregabalin) receives positive CVMP opinion. ORION CORPORATION PRESS RELEASE 17 MAY 2021 at 15.00 EEST. The Committee for Medical Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has recommended Bonqat® (pregabalin) for marketing authorisation in the European Union. INTRODUCING THE TURKU SITE: 4+ DECADES OF GMP COMPLIANT Introducing the Turku site: 4+ decades of GMP compliant pharma manufacturing. With 45 years of experience in GMP compliant pharma production, and its own R&D unit, Orion’s Turku site focuses especially on tablets, hormonal gels and semisolids, creams and ointments as well as anti-cancer drugs – and caters to all globalmarkets.
ORION'S AND BAYER'S DAROLUTAMIDE SHOWS SUBSTANTIAL Abstract: 140 - ARAMIS Results from the pivotal Phase III ARAMIS trial in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) showed a statistically significant improvement in metastasis-free survival (MFS) with darolutamide plus standard of care (ADT) compared to placebo plus ADT (HR=0.41, 95% CI 0.34-0.50; PDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0